These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29693201)

  • 21. Ceritinib Enhances the Efficacy of Substrate Chemotherapeutic Agent in Human ABCB1-Overexpressing Leukemia Cells In Vitro, In Vivo and Ex-Vivo.
    Yang L; Li M; Wang F; Zhen C; Luo M; Fang X; Zhang H; Zhang J; Li Q; Fu L
    Cell Physiol Biochem; 2018; 46(6):2487-2499. PubMed ID: 29742496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resveratrol induces AMPK-dependent MDR1 inhibition in colorectal cancer HCT116/L-OHP cells by preventing activation of NF-κB signaling and suppressing cAMP-responsive element transcriptional activity.
    Wang Z; Zhang L; Ni Z; Sun J; Gao H; Cheng Z; Xu J; Yin P
    Tumour Biol; 2015 Dec; 36(12):9499-510. PubMed ID: 26124005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment.
    Wang D; Xu X; Zhang K; Sun B; Wang L; Meng L; Liu Q; Zheng C; Yang B; Sun H
    Int J Nanomedicine; 2018; 13():187-198. PubMed ID: 29343957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysregulated MDR1 by PRDM1/Blimp1 Is Involved in the Doxorubicin Resistance of Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
    Qing K; Jin Z; Xu Z; Wang W; Li X; Zhang Y; Wang L; Zhu H; Xiang R; Wu S; Li R; Jiang G; Xue K; Li J
    Chemotherapy; 2022; 67(1):12-23. PubMed ID: 34844236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-kappaB-mediated increase of intracellular doxorubicin accumulation.
    van Wijngaarden J; van Beek E; van Rossum G; van der Bent C; Hoekman K; van der Pluijm G; van der Pol MA; Broxterman HJ; van Hinsbergh VW; Löwik CW
    Eur J Cancer; 2007 Jan; 43(2):433-42. PubMed ID: 17097285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visfatin mediates doxorubicin resistance in human non-small-cell lung cancer via Akt-mediated up-regulation of ABCC1.
    Cao Z; Liang N; Yang H; Li S
    Cell Prolif; 2017 Oct; 50(5):. PubMed ID: 28762597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer.
    Velaei K; Samadi N; Soltani S; Barazvan B; Soleimani Rad J
    Breast Cancer; 2017 Jul; 24(4):552-561. PubMed ID: 27878697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melanoma differentiation associated gene-7/interleukin-24 reverses multidrug resistance in human colorectal cancer cells.
    Emdad L; Lebedeva IV; Su ZZ; Sarkar D; Dent P; Curiel DT; Fisher PB
    Mol Cancer Ther; 2007 Nov; 6(11):2985-94. PubMed ID: 18025283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NFκB pathway in H9c2 cardiac cells.
    Guo R; Wu K; Chen J; Mo L; Hua X; Zheng D; Chen P; Chen G; Xu W; Feng J
    Cell Physiol Biochem; 2013; 32(6):1668-80. PubMed ID: 24356372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells.
    Hien TT; Kim HG; Han EH; Kang KW; Jeong HG
    Mol Nutr Food Res; 2010 Jul; 54(7):918-28. PubMed ID: 20077420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Addressing reported pro-apoptotic functions of NF-kappaB: targeted inhibition of canonical NF-kappaB enhances the apoptotic effects of doxorubicin.
    Bednarski BK; Baldwin AS; Kim HJ
    PLoS One; 2009 Sep; 4(9):e6992. PubMed ID: 19746155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression.
    Sugiu K; Tazawa H; Hasei J; Yamakawa Y; Omori T; Komatsubara T; Mochizuki Y; Kondo H; Osaki S; Fujiwara T; Yoshida A; Kunisada T; Ueda K; Urata Y; Kagawa S; Ozaki T; Fujiwara T
    Cancer Chemother Pharmacol; 2021 Sep; 88(3):513-524. PubMed ID: 34114067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Icariin enhances cytotoxicity of doxorubicin in human multidrug-resistant osteosarcoma cells by inhibition of ABCB1 and down-regulation of the PI3K/Akt pathway.
    Wang Z; Yang L; Xia Y; Guo C; Kong L
    Biol Pharm Bull; 2015; 38(2):277-84. PubMed ID: 25747987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Doxorubicin induces atypical NF-κB activation through c-Abl kinase activity in breast cancer cells.
    Esparza-López J; Medina-Franco H; Escobar-Arriaga E; León-Rodríguez E; Zentella-Dehesa A; Ibarra-Sánchez MJ
    J Cancer Res Clin Oncol; 2013 Oct; 139(10):1625-35. PubMed ID: 23892407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemosensitization by diverging modulation by short-term and long-term TNF-α action on ABCB1 expression and NF-κB signaling in colon cancer.
    Walther W; Kobelt D; Bauer L; Aumann J; Stein U
    Int J Oncol; 2015 Dec; 47(6):2276-85. PubMed ID: 26463665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
    Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
    Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted delivery of doxorubicin through conjugation with EGF receptor-binding peptide overcomes drug resistance in human colon cancer cells.
    Ai S; Jia T; Ai W; Duan J; Liu Y; Chen J; Liu X; Yang F; Tian Y; Huang Z
    Br J Pharmacol; 2013 Apr; 168(7):1719-35. PubMed ID: 23146125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of G-Protein-Coupled Estrogen Receptor Inhibits the Migration of Human Nonsmall Cell Lung Cancer Cells via IKK-β/NF-κB Signals.
    Zhu G; Huang Y; Wu C; Wei D; Shi Y
    DNA Cell Biol; 2016 Aug; 35(8):434-42. PubMed ID: 27082459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of NF-kappaB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines.
    García MG; Alaniz L; Lopes EC; Blanco G; Hajos SE; Alvarez E
    Leuk Res; 2005 Dec; 29(12):1425-34. PubMed ID: 15982733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
    Buondonno I; Gazzano E; Jean SR; Audrito V; Kopecka J; Fanelli M; Salaroglio IC; Costamagna C; Roato I; Mungo E; Hattinger CM; Deaglio S; Kelley SO; Serra M; Riganti C
    Mol Cancer Ther; 2016 Nov; 15(11):2640-2652. PubMed ID: 27466354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.